Proscia Tops KLAS Digital Pathology Rankings with 95.2 Score
Event summary
- Proscia earned the highest overall performance score (95.2) in KLAS Research's 2026 Digital Pathology report, based on US customer feedback.
- The company is the first digital pathology vendor to top KLAS rankings across multiple regions in the same year.
- Concentriq platform supports integrations with 15+ laboratory information systems and serves as an interoperable hub for third-party AI applications.
- Proscia achieved SOC 2 Type II compliance, underscoring enterprise-grade security and operational rigor.
The big picture
Proscia's top performance score in KLAS Research's Digital Pathology report highlights the growing importance of digital transformation in healthcare. As laboratories plan for expanding case volumes and navigate complex technology ecosystems, Proscia's Concentriq platform offers a strategic advantage with its interoperability and AI integration capabilities. The company's SOC 2 Type II compliance further solidifies its position as a trusted vendor in the digital pathology space.
What we're watching
- Market Expansion
- Whether Proscia can sustain its leadership position in digital pathology across multiple regions.
- Integration Strategy
- How the pace of AI integration into routine workflows will impact Concentriq's market share.
- Revenue Growth
- The extent to which Proscia can monetize real-world pathology data and expand its role in precision medicine.
Related topics